Aceragen | 4: Statement of changes in beneficial ownership of securities-Director GOWEN MAXINE
Aceragen | 4: Statement of changes in beneficial ownership of securities-Director MILANO VINCENT
Aceragen | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pillar Pharmaceuticals 6, L.P.(1.0%),Pillar Partners Foundation, L.P.(1.0%), etc.
Aceragen | 4: Statement of changes in beneficial ownership of securities-10% Owner Pillar Invest Corp
Aceragen | 4: Statement of changes in beneficial ownership of securities-10% Owner Pillar Invest Corp
Aceragen | 3/A: Initial statement of beneficial ownership of securities (Amendment)-10% Owner Pillar Invest Corp
Aceragen | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Abude Umari(8.7%),Pillar Pharmaceuticals 6, L.P.(6.7%), etc.
Aceragen | 3: Initial statement of beneficial ownership of securities-10% Owner Pillar Invest Corp
Aceragen | 4: Statement of changes in beneficial ownership of securities-10% Owner Chopra Atul
Aceragen | 4: Statement of changes in beneficial ownership of securities-10% Owner Chopra Atul
Aceragen | 4: Statement of changes in beneficial ownership of securities-10% Owner Chopra Atul
Aceragen | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Abude Umari(9.5%),Pillar Pharmaceuticals 6, L.P.(9.3%), etc.
Aceragen | SC 13D: Statement of acquisition of beneficial ownership by individuals-Atul Chopra, MD, PhD, as trustee of the Chopra Revocable Trust(17.4%)
Aceragen | 3: Initial statement of beneficial ownership of securities-10% Owner Chopra Atul
Aceragen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Castellina Ventures Ltd.(3.3%),Ballaison Trust(3.3%)
Aceragen | 4: Statement of changes in beneficial ownership of securities
Aceragen | 4: Statement of changes in beneficial ownership of securities
Aceragen | 4: Statement of changes in beneficial ownership of securities
Aceragen | 4: Statement of changes in beneficial ownership of securities
Aceragen | 4: Statement of changes in beneficial ownership of securities